Mar
17
2020

Podcast on Digital Health - Released March 19th 2020

Listen to Dr. Randy Vogenberg talk about Digital Health on the Relentless Health Value Podcast this thursday, March 19th at 7:35 am EST. https://relentlesshealthvalue.com/audios/ep265/
Mar
16
2020

Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence

PROVIDERS: Medicare coverage represents a significant source of revenue and patients for healthcare providers. The management of chronic conditions constitutes key therapeutic strategies that rely heavily on the use of medications, so expanding our understanding of drug use in this populatio...
Mar
16
2020

Expert Roundtable: Drug Pricing

Our experts analyze pending legislation, branded drug price increase trends, the real impact of the record number of generic drug approvals, and the value of presidential executive action. According to the Kaiser Family Foundation’s (KFF) October 2019 Health Tracking Poll, nearly 80% ...
Feb
19
2020

The Opioid Crisis and What Has Been Learned

So much to write, so little space. A real challenge for healthcare professionals (HCPs) and responsible healthcare organization operating committees like P&T is walking back care delivery and pharmaceutical prescribing practices that have existed for more than a century. Numerous lawsuits h...
Jan
24
2020

Digital Health: A New-Age Spectrum of Therapeutics

Digital Health: A New-Age Spectrum of Therapeutics Timothy Aungst, PharmD; and F. Randy Vogenberg, PhD, RPh Download the Article
Dec
23
2017

Welcome to the new EPIC Website!

Welcome to the new EPIC website. EPIC is creating a group of resources that include white papers, educational programs, pharmacoecominic assesments, interactive case studies, and guidelines for best practices written by thought leaders working in employer-provider interface.
Dec
23
2017

The current US healthcare system falls short in utilizing healthcare economic information (HCEI) to accurately manage spending on prescription drugs, diagnostics, and devices.

This article describes how recent FDA guidance and improved HCEI communication between drug manufacturers and payers help create a formulary and budgeting framework that could translate to more affordable access to drugs for patients. View Article